跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LECIGON levodopa 20 mg/mL / carbidopa monohydrate 5 mg/mL / entacapone 20 mg/mL intestinal gel cartridge - TGA Drug Approval Details
Approvals
/
TGA
/
LECIGON levodopa 20 mg/mL / carbidopa monohydrate 5 mg/mL / entacapone 20 mg/mL intestinal gel cartridge
Approved
STANDARD
LECIGON levodopa 20 mg/mL / carbidopa monohydrate 5 mg/mL / entacapone 20 mg/mL intestinal gel cartridge
Stada Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c9e671891ab49a9a
Company
Stada Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c9e671891ab49a9a
Product Name
LECIGON levodopa 20 mg/mL / carbidopa monohydrate 5 mg/mL / entacapone 20 mg/mL intestinal gel cartridge
Artg Id
377437
Artg Name
LECIGON levodopa 20 mg/mL / carbidopa monohydrate 5 mg/mL / entacapone 20 mg/mL intestinal gel cartridge
Sponsor
Stada Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/stada-pharmaceuticals-australia-pty-limited
Artg Date
2023-09-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/eceb66fbf114cb9d9ad8d0725d8a86e1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c9e206f3a26e251c776bdaf4eaea7a23.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c9e671891ab49a9a
Type
Standard
Back to TGA Approvals